PRXL Share Price

Open 65.88 Change Price %
High 66.36 1 Day 0.06 0.09
Low 65.31 1 Week -0.25 -0.38
Close 65.94 1 Month -4.40 -6.26
Volume 50600 1 Year 7.38 12.60
52 Week High 72.32
52 Week Low 51.16
PRXL Important Levels
Resistance 2 66.91
Resistance 1 66.51
Pivot 65.87
Support 1 65.37
Support 2 64.97
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

PAREXEL International Corporation (NASDAQ: PRXL)

PRXL Technical Analysis 1.5
As on 24th Feb 2017 PRXL Share Price closed @ 65.94 and we RECOMMEND Buy for LONG-TERM with Stoploss of 64.55 & Sell for SHORT-TERM with Stoploss of 66.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRXL Target for February
1st Target up-side 74.57
2nd Target up-side 77.16
3rd Target up-side 79.74
1st Target down-side 67.21
2nd Target down-side 64.62
3rd Target down-side 62.04
PRXL Other Details
Segment EQ
Market Capital 1867869184.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.parexel.com
PRXL Address
PRXL
195 West Street
Waltham, MA 02451
United States
Phone: 781-487-9900
Fax: 781-487-0525
Interactive Technical Analysis Chart PAREXEL International Corporation ( PRXL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PAREXEL International Corporation
PRXL Business Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. It operates it three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS) and Perceptive Informatics, Inc. (Perceptive). The Company�s product and service offerings include clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics / outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, post-marketing surveillance. In May 2013, PAREXEL International Corp acquired the entire share capital of HERON Group Ltd.